唐明希 - 西南医科大学

个人简介

男，医学博士, 副教授，硕士研究生导师。1999年毕业于重庆医科大学临床医学专业，2000年获日本奖学金，进入日本名古屋市立大学医学部留学：2000.12-2003.3 实验病态病理和肿瘤生物学研究生；2003.4-2007.3实验病态病理和肿瘤生物学博士； 2007.4-2009.3实验病态病理和肿瘤生物学博士后。2009.3月进入四川省泸州医学院病理教研室（科）主要从事科研、教学及临床分子病理工作。

研究领域

主要借助于实验病理学、分子生物学、肿瘤生物学等研究（1）肿瘤的发生，发展和转移的机制；（2）前列腺癌化学预防、化学治疗及综合基因治疗。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Satoru Takahashi1, Hiroji Uemura, Azman Seeni1,Mingxi Tang, Masami Komiya, Ne Long, Hitoshi Ishiguro, Yoshinobu Kubota and Tomoyuki Shirai. Therapeutic Targeting of Angiotensin II Receptor Type 1 to Regulate Androgen Receptor in Prostate Cancer. Prostate. 2012;accepted (SCI,IF:3.16) 2. Mingxi Tang, Kumiko Ogawa, Makoto Asamoto, Teera Chewonarin, Shugo Suzuki,Tomoyuki Shirai. Effects of Nobiletin on PhIP Induced Prostate and Colon Carcinogenesis in F344 Rats. Nutr Cancer.2011;63(2):227-233. (SCI,IF:2.84 ) 3. Kentaro T, Satoru T, Mingxi T,Azman S, Makoto A and Tomoyuki S. Hypertension is positively associated with prostate cancer development in the TRAP transgenic rat model. Pathol Int.2011;61(4):202-9. (SCI,IF:1.568) 4. Qian Chen, Mingxi Tang, Takayoshi mamiya, Heh-In Im, XiaoLi Xiong, Anu Joseph, Ya-Ping Tang. Bi-Directional Effect of Cholecystokinin Receptor-2 Overexpression on Stress-Triggered Fear Memory and Anxiety in the Mouse. PLoS One.2010,5(12): e15999 (SCI,IF:4.61) 5. Mingxi Tang, Makoto Asamoto, Kumiko Ogawa, Aya Naiki-Ito, Shinva Sato,Satoru Takahashi,Tomoyuki Shirai. Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk Inhibitor. Pathol Int.2009;59(11):790-96. (SCI,IF:1.568) 6. Mingxi Tang, Kumiko Ogawa, Makoto Asamoto, Hokaiwado Naomi, Seeni Azman, Suzuki S, Takahashi S, Tanaka T,Ichikawa K, Tomoyuki Shirai. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 2007;98(4):471-7.(SCI,IF:4.023) 7. Takakashi S, Takeshita K, Seeni A, Suqiura S, Tang M, Sato SY, Kuriyama H, Nakadate M, Abe K, Maeno Y, Naqao M, Shirai T. Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Prostate. 2009;69(6):644-51 (SCI,IF:3.16) 8. Azman S, Takahashi S, Takeshita K, Tang MX, Sugiura S, Sato S, Shirai T. Suppression of Prostate Cancer Growth by Resveratrol in the Transgenic Rat for Adenocarcinoma of Prostate (TRAP) model. Asian Pacific J Cancer Prev. 2008;9(1):7-14 (SCI,IF:1.24) 9. Y-M Cho, S Takahashi, M Asamoto, S Suzuki, M Tang and Tomoyuki Shirai. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostateic lesions in a transgenic rat model. Prostate Cancer and Prostatic Dis. 2007;10(4):378-83 (SCI,IF:2.263) 10. Mahmoud M Said, Naomi H, Mingxi Tang, Ogawa K, Suzuki S, Hala M Ghanem, Amr Y Esmat, Asamoto M, Fawzia M Refaie, Shirai T. Chemoprevention of prostate carcinogenesis in Probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone-releasing hormone agonist. Cancer Sci. 2006;97(6):459-67 (SCI,IF:4.023) 11. Ogawa K, Masutani M, Kato K, Tang M, Kamada N,Suzuki H, Nakagama H, Sugimura T, Shirai. Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice. Cancer Lett. 2006; 236 (1):32-8 (SCI,IF: 4.105) 12. Yamada T, Kuno A, Ogawa K, Tang M, Masuda K, Nakamura S, Ando T, Okamoto T, Ohara H, Nomura T, Joh T, Shirai T, Itoh M. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin 2 receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther. 2005;313(1):36-45. (SCI,IF: 4.089) 13. Okamoto T, Yamada T, Kuno A, Ogawa K, Tang M, Sano H, Ohara H, Nakao H. Kataoka H, Shirai T, Itoh M. FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration. Pancreas.2005; 30(3):e64-70. (SCI,IF:2.634) 14. Kandori H, Suzuki S, Asamoto M, Murasaki Tang M, Ogawa K, Shirai T. Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci. 2005; 96(4):221-6. (SCI,IF:4.023) 15. Ikeda Y, Cho YM, Takahashi S, Tang M, Asamoto M, Ogawa K, Shirai T. Equivocal impact of transplacental and lactational exposure to a food-derived carcinogen, 2-amino—methy1-6-phenylimidazo[4,5-b]pyridine, on prostate and colon lesion development in F344 rats. Cancer Lett.2005; 224(1):23-30. (SCI,IF: 4.105)